Volume : 08, Issue : 04, April – 2021
Title:
40.REDUCING RISK OF CARDIOVASCULAR DISEASES AMONG GENERAL POPULATIONS – REVIEW
Authors :
Dr. Fatma Saleh Alharbi, Dr. Suzan Bakur Natto, Sahar Malian Abdulhaleem, Mufleh Falhan Almqati, Mazen Munir Matar, Essa Safar Algamdi, Yasser Ahmed Saigh, Helal Hussin Zamil, Alaa Abdullah Rawah, Abdulrahman Saad Alsaedi
Abstract :
Cardiovascular disease (CVD) is a long-term condition with serious and often deadly consequences. In this review, we highlight the main areas targeted for primary CVD prevention in primary care, as well as recommendations to minimize CHD risk. This is accomplished by searching electronic databases (MEDLINE, Embase, SCOPUS, CINAHL,) for published articles prevention measures in lowering the risk of coronary heart disease (CHD). Primary prevention programs aimed at reducing risk behaviors on a population-wide scale, as well as the identification, stratification, and also targeted treatment of high-risk individuals prior to the progression of condition, should be cornerstones of any strategy to reduce the population’s fear of CHD and also, prevention strategies must start in childhood.
Cite This Article:
Please cite this article in press Fatma Saleh Alharbi et al., Reducing Risk Of Cardiovascular Diseases Among General Populations – Review.., Indo Am. J. P. Sci, 2021; 08(04).
Number of Downloads : 10
References:
1. WHO. Cardiovascular diseases (CVDs). 2016. Available at: http://www.who.int/mediacentre/factsheets/fs317/en/ (accessed 10 October 2016).
2. Lopez AD. Assessing the burden of mortality from cardiovascular diseases. World Health Star. Q. 1993;46:91–96.
3. Dodu SRA. Emergence of cardiovascular disease in developing countries. Cardiology. 1988;75:56–64.
4. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2010;122:e584–636.
5. Cohen R, Budoff M, McClelland RL, Sillau S, Burke G, Blaha M, et al. Significance of a positive family history for coronary heart disease in patients with a zero coronary artery calcium score (from the multi-ethnic study of atherosclerosis) Am J Cardiol. 2014;114:1210–4.
6. Goff DC, Jr, Lloyd-Jones DM, Bennett G, Coady S, D’Agostino RB, Gibbons R, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S49–73.
7. World Health Organization. Prevention of Recurrent Heart Attacks and Strokes in Low and Middle Income Populations. Evidence-Based Recommendations for Policy Makers and Health Professionals. Geneva: 2003. [Last accessed on 2017 Jul 25]. Available from: http://www.who.int/bookorders .
8. Hobbs FDR. Cardiovascular disease: different strategies for primary and secondary prevention? Heart. 2004;90(10):1217-1223. doi:10.1136/hrt.2003.027680.
9. Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2016; 37: 2315–2381.
10. Eckel RH, Jakicic JM, Ard JD, et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013. 2014: 63(25_PA).
11. NICE. Cardiovascular disease: risk assessment and reduction, including lipid modification. NICE Guideline CG181, 2016.
12. Perk J, De Backer G, Gohlke H, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). Eur Heart J 2012; 33: 1635–1701.
13. de Souza RJ, Mente A, Maroleanu A, et al. Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies. BMJ 2015; 351: h3978–h3978.
14. Kottke TE, Battista RN, DeFriese GH, et al. Attributes of successful smoking cessation interventions in medical practice: a meta-analysis of 39 controlled trials. JAMA 1988; 259: 2882–2889.
15. Tzivoni D, Keren A, Meyler S, et al. Cardiovascular safety of transdermal nicotine patches in patients with coronary artery disease who try to quit smoking. Cardiovasc Drugs Ther 1998; 12: 239–244.
16. Bhatnagar A. E-Cigarettes and cardiovascular disease risk: evaluation of evidence, policy implications, and recommendations. Curr Cardiovasc Risk Rep 2016; 10: 1–10.
17. Khosravi A, Akhavan Tabib A, Golshadi I, et al. The relationship between weight and CVD risk factors in a sample population from central Iran (based on IHHP). ARYA Atheroscler 2012; 8: 82–89.